Evaluation of autoCPAP devices in home treatment of sleep apnea/hypopnea syndrome

Background and purposeQuality of life (QOL) and sleepiness for patients with sleep apnea/hypopnea syndrome (SAHS) might improve with continuous positive airway pressure devices working in auto-adjust mode (autoCPAP) by allowing pressure modulations following patient needs. Clinical comparisons between devices driven by different algorithms are needed.MethodsWe compared the clinical effectiveness of fixed pressure CPAP and four different autoCPAP devices by assessing compliance and QOL (36-item short-form health survey [SF-36]). SAHS patients were randomly allocated to five groups. Polysomnography (PSG) was performed to titrate the effective pressure in the constant CPAP group and evaluate residual apnea/hypopnea index (AHI) under autoCPAP. Follow-up consisted of clinical visits at three and six months by homecare technicians who assessed compliance, symptom scores and SF-36 scores. A laboratory-based PSG using the same CPAP/autoCPAP device as at home was performed at six months.ResultsEighty-three patients (mean age 56 ± 10 yrs) with mean body mass index (BMI) 30.8 ± 5.3 kg/m2 and severe SAHS (mean AHI: 52.3 ± 17.8/h) were included. There were no differences in clinical symptoms or QOL scores, and similar clinical and PSG improvements were seen in all groups. CPAP use was >5 h per night, without any significant difference between groups.ConclusionsAutoCPAP is equally as effective as fixed CPAP for long-term home treatment in severe SAHS patients.